Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 5th edition, 486 pages Free download

Prostate Cancer

Free Subscription 16.11.2020 1 BJU Int 1 Cancer 1 Cancer Lett 7 Eur Urol 1 Int J Radiat Oncol Biol Phys 4 J Nucl Med 4 J Urol 1 Nat Rev Cancer 2 Nat Rev Urol 2 PLoS One 2 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BJU Int

1. POULSON M, Helrich S, Kenzik K, Dechert T, et al
   The Impact of Residential Segregation on Prostate Cancer Diagnosis and Treatment.
   BJU Int. 2020 Nov 9. doi: 10.1111/bju.15293.
   PubMed         Abstract available
   
   

   
   Cancer

2. WASHINGTON SL 3RD, Master VA
   Health literacy and shared decision making in prostate cancer screening: Equality versus equity.
   Cancer. 2020 Nov 9. doi: 10.1002/cncr.33235.
   PubMed        
   
   

   
   Cancer Lett

3. LEECH M, Osman S, Jain S, Marignol L, et al
   Mini review: Personalization of the radiation therapy management of prostate cancer using MRI-based radiomics.
   Cancer Lett. 2020 Nov 4. pii: S0304-3835(20)30565.
   PubMed         Abstract available
   
   

   
   Eur Urol

4. VICKERS A, Carlsson SV, Cooperberg M
   Reply to Yi Sun, Fengxiang Sun, Qiang Wei, Jin Huang, and Ruiqi Duan's Letter to the Editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine Use of Magnetic Resonance Imaging for Early Detection of Prostate Cancer Is Not Justified b
   Eur Urol. 2020 Nov 3. pii: S0302-2838(20)30786.
   PubMed        
   
   
5. GOMEZ SL, Washington SL 3rd, Cheng I, Huang FW, et al
   Monitoring Prostate Cancer Incidence Trends: Value of Multiple Imputation and Delay Adjustment to Discern Disparities in Stage-specific Trends.
   Eur Urol. 2020 Nov 2. pii: S0302-2838(20)30811.
   PubMed        
   
   
6. RUIZ DE PORRAS V, Wang XC, Palomero L, Marin-Aguilera M, et al
   Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
   Eur Urol. 2020 Nov 2. pii: S0302-2838(20)30778.
   PubMed         Abstract available
   
   
7. BANGMA CH, van Leenders GJLH, Roobol MJ, Schoots IG, et al
   Restricting False-positive Magnetic Resonance Imaging Scans to Reduce Overdiagnosis of Prostate Cancer.
   Eur Urol. 2020 Nov 5. pii: S0302-2838(20)30790.
   PubMed        
   
   
8. FERREIRA COELHO R, Afonso de Carvalho P, Betoni Guglielmetti G, Dener Cordeiro M, et al
   Reply to Francesco Montorsi, Giorgio Gandaglia, Christoph Wurnschimmel, Markus Graefen, Alberto Briganti, and Hartwig Huland's Letter to the Editor re: Paolo Afonso de Carvalho, Joao A.B.A. Barbosa, Giuliano B. Guglielmetti, et al. Retrograde Release
   Eur Urol. 2020 Nov 5. pii: S0302-2838(20)30689.
   PubMed        
   
   
9. MOTTET N, van den Bergh RCN, Briers E, Van den Broeck T, et al
   EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
   Eur Urol. 2020 Nov 7. pii: S0302-2838(20)30769.
   PubMed         Abstract available
   
   
10. NEEB A, Herranz N, Arce-Gallego S, Miranda S, et al
    Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors.
    Eur Urol. 2020 Nov 8. pii: S0302-2838(20)30836.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

11. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    PubMed         Abstract available
    
    

    
    J Nucl Med

12. BARATTO L, Duan H, Macke H, Iagaru A, et al
    Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer.
    J Nucl Med. 2020;61:792-798.
    PubMed         Abstract available
    
    
13. EMMETT L, Tang R, Nandurkar RH, Hruby G, et al
    3-year freedom from progression following (68)GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial.
    J Nucl Med. 2019 Nov 1. pii: jnumed.119.235028. doi: 10.2967/jnumed.119.235028.
    PubMed         Abstract available
    
    
14. CZERNIN J
    Two Leaders.
    J Nucl Med. 2020;61:773.
    PubMed        
    
    
15. SOULE HR, Czernin J
    A Conversation Between Howard Soule and Johannes Czernin.
    J Nucl Med. 2020;61:774-776.
    PubMed        
    
    

    
    J Urol

16. SCHENK JM, Newcomb LF, Zhu K, Zheng Y, et al
    Re: African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.
    J Urol. 2020 Nov 6:101097JU0000000000001444. doi: 10.1097/JU.0000000000001444.
    PubMed        
    
    
17. TANEJA SS
    Urological Oncology: Prostate Cancer.
    J Urol. 2020 Nov 12:101097JU0000000000001472. doi: 10.1097/JU.0000000000001472.
    PubMed        
    
    
18. MAGGI M, Cowan JE, Fasulo V, Washington SL 3rd, et al
    The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer.
    J Urol. 2020;204:1222-1228.
    PubMed         Abstract available
    
    
19. POWELL IJ, Heilbrun LK, Kittles RA
    RE: African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from Canary Prostate Cancer Active Surveillance Study.
    J Urol. 2020 Nov 6:101097JU0000000000001443. doi: 10.1097/JU.0000000000001443.
    PubMed        
    
    

    
    Nat Rev Cancer

20. DE BONO JS, Guo C, Gurel B, De Marzo AM, et al
    Prostate carcinogenesis: inflammatory storms.
    Nat Rev Cancer. 2020;20:455-469.
    PubMed         Abstract available
    
    

    
    Nat Rev Urol

21. TREGUNNA R
    Serum MMP7 levels could guide metastatic therapy for prostate cancer.
    Nat Rev Urol. 2020 Nov 10. pii: 10.1038/s41585-020-00396.
    PubMed        
    
    
22. WILKINS LJ, Tosoian JJ, Sundi D, Ross AE, et al
    Surgical management of high-risk, localized prostate cancer.
    Nat Rev Urol. 2020 Nov 10. pii: 10.1038/s41585-020-00384.
    PubMed         Abstract available
    
    

    
    PLoS One

23. TAKAKUSAGI Y, Oike T, Kano K, Anno W, et al
    Prostate-specific antigen dynamics after neoadjuvant androgen-deprivation therapy and carbon ion radiotherapy for prostate cancer.
    PLoS One. 2020;15:e0241636.
    PubMed         Abstract available
    
    
24. MCNABB E, Al-Mahrouki A, Law N, McKay S, et al
    Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation.
    PLoS One. 2020;15:e0239456.
    PubMed         Abstract available
    
    

    
    Urology

25. GREENBERG JW, Leinwand G, Feibus AH, Haney NM, et al
    Prospective Observational Study of a Racially Diverse Group of Men on Active Surveillance for Prostate Cancer.
    Urology. 2020 Nov 6. pii: S0090-4295(20)31346.
    PubMed         Abstract available
    
    
26. SOETERIK TFW, van Melick HHE, Dijksman LM, Biesma DH, et al
    Multi-parametric magnetic resonance imaging should be preferred over digital rectal examination for prostate cancer local staging and disease risk classification.
    Urology. 2020 Oct 28. pii: S0090-4295(20)31296.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: